NasdaqGS - Delayed Quote USD

Relmada Therapeutics, Inc. (RLMD)

Compare
3.6400 +0.0100 (+0.28%)
At close: October 22 at 4:00 PM EDT

Insider Purchases Last 6 Months

SharesTransactions
Purchases 0 0
Sales -- 0
Net Shares Purchased (Sold) 0 0
Total Insider Shares Held 2.43M --
% Net Shares Purchased (Sold) -- --

Net Institutional Purchases Prior Quarter to Latest Quarter

Shares
Net Shares Purchased (Sold) --
% Change in Institutional Shares Held --

Insider Transactions Reported - Last Two Years

InsiderTransactionTypeValueDate
TRAVERSA SERGIO Chief Executive Officer Purchase at price 2.71 - 2.99 per share. Direct 395,115 Sep 11, 2024
SHENOUDA MAGED R Chief Financial Officer Purchase at price 2.55 - 2.95 per share. Direct 149,701 Sep 11, 2024
CASAMENTO CHARLES J Director Purchase at price 2.56 per share. Direct 33,280 Sep 9, 2024
KELLY PAUL EDWARD Director Purchase at price 2.59 per share. Direct 64,750 Sep 9, 2024
TRAVERSA SERGIO Chief Executive Officer Purchase at price 3.71 - 4.00 per share. Direct 386,738 Jan 31, 2024
SHENOUDA MAGED R Chief Financial Officer Purchase at price 3.65 - 4.06 per share. Direct 125,717 Jan 31, 2024
ENCE CHARLES Officer Purchase at price 3.65 - 4.05 per share. Direct 150,920 Jan 31, 2024
O'GORMAN CEDRIC Officer Purchase at price 3.18 per share. Direct 31,800 May 23, 2023
TRAVERSA SERGIO Chief Executive Officer Purchase at price 2.10 per share. Direct 115,804 Dec 8, 2022

Related Tickers